Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.849
-0.014 (-1.59%)
At close: Apr 28, 2026, 4:00 PM EDT
0.898
+0.049 (5.72%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Vivos Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Vivos Therapeutics stock have an average target of 2.75, with a low estimate of 2.50 and a high estimate of 3.00. The average target predicts an increase of 223.76% from the current stock price of 0.85.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vivos Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5.5 → $3 | Strong Buy | Maintains | $5.5 → $3 | +253.19% | Apr 22, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $2.5 | Strong Buy | Maintains | $7 → $2.5 | +194.33% | Apr 17, 2026 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.5 → $5.5 | Strong Buy | Maintains | $6.5 → $5.5 | +547.52% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +724.11% | Nov 17, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $6.2 → $6.5 | Strong Buy | Maintains | $6.2 → $6.5 | +665.25% | Sep 9, 2025 |
Financial Forecast
Revenue This Year
29.59M
from 17.44M
Increased by 69.66%
Revenue Next Year
n/a
from 29.59M
EPS This Year
-1.28
from -2.06
EPS Next Year
n/a
from -1.28
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | 33.1M |
| Avg | 29.6M |
| Low | 22.5M |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | 89.6% |
| Avg | 69.7% |
| Low | 29.2% |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -0.89 |
| Avg | -1.28 |
| Low | -1.68 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.